scholarly journals Comparison of Minimally Invasive Tubular Surgery with Conventional Surgery in the Treatment of Thoracolumbar Metastasis

2021 ◽  
Vol Volume 13 ◽  
pp. 8399-8409
Author(s):  
Yunpeng Cui ◽  
Xuedong Shi ◽  
Chuan Mi ◽  
Bing Wang ◽  
Yuanxing Pan ◽  
...  
2011 ◽  
Vol 26 (2) ◽  
pp. 350-356 ◽  
Author(s):  
Sharon P. Rodrigues ◽  
Aurystella M. Wever ◽  
Jenny Dankelman ◽  
Frank W. Jansen

2021 ◽  
Author(s):  
Xuedong Shi ◽  
Yunpeng Cui ◽  
Chuan Mi ◽  
Bing Wang ◽  
Chunwei Li ◽  
...  

Abstract Background: This study aims to evaluate the perioperative safety and efficacy of minimally-invasive tubular surgery for spinal metastasis with different blood supply.Methods: 72 patients with spinal metastasis between January 2011 to June 2020 were retrospectively reviewed. 14 patients underwent minimally-invasive tubular surgery (Mini-invasive group), and 58 patients underwent conventional surgery (Conventional group). T-test and Mann–Whitney U test was used to evaluate the difference in demographic and perioperative data between the two groups.Results: Baseline characteristics did not differ significantly between the two groups except for the Tokuhashi score (p=0.036). Overall, conventional group had significantly more blood loss (P=0.001), blood transfused(P=0.027), drainage(P<0.001), and longer time of drainage tube(P<0.001), postoperative hospitalization(P=0.002) compared with the mini-invasive group. Sub-analysis showed that for patients with hypo-vascular tumor, trans-channel decompression surgery had all advantages mentioned above. For patients with hyper-vascular tumor, trans-channel decompression surgery only had advantages on the drainage related events. Patients with hyper-vascular tumor had significantly more blood loss compared with patients with hypo-vascular tumor among mini-invasive group.Conclusion: In selected cases with spinal metastasis, minimally-invasive tubular surgery is safe and effective for patients with spinal metastasis. Patients with hypo-vascular tumor were more suitable for this technique with less blood loss, less blood transfused, less drainage and shorter postoperative hospitalization.


Author(s):  
Leandro Cardoso BARCHI ◽  
Carlos Eduardos JACOB ◽  
Cláudio José Caldas BRESCIANI ◽  
Osmar Kenji YAGI ◽  
Donato Roberto MUCERINO ◽  
...  

ABSTRACT Introduction: Minimally invasive surgery widely used to treat benign disorders of the digestive system, has become the focus of intense study in recent years in the field of surgical oncology. Since then, the experience with this kind of approach has grown, aiming to provide the same oncological outcomes and survival to conventional surgery. Regarding gastric cancer, surgery is still considered the only curative treatment, considering the extent of resection and lymphadenectomy performed. Conventional surgery remains the main modality performed worldwide. Notwithstanding, the role of the minimally invasive access is yet to be clarified. Objective: To evaluate and summarize the current status of minimally invasive resection of gastric cancer. Methods: A literature review was performed using Medline/PubMed, Cochrane Library and SciELO with the following headings: gastric cancer, minimally invasive surgery, robotic gastrectomy, laparoscopic gastrectomy, stomach cancer. The language used for the research was English. Results: 28 articles were considered, including randomized controlled trials, meta-analyzes, prospective and retrospective cohort studies. Conclusion: Minimally invasive gastrectomy may be considered as a technical option in the treatment of early gastric cancer. As for advanced cancer, recent studies have demonstrated the safety and feasibility of the laparoscopic approach. Robotic gastrectomy will probably improve outcomes obtained with laparoscopy. However, high cost is still a barrier to its use on a large scale.


2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Marek Pojar ◽  
Mikita Karalko ◽  
Martin Dergel ◽  
Jan Vojacek

Abstract Objectives Conventional mitral valve surgery through median sternotomy improves long-term survival with acceptable morbidity and mortality. However, less-invasive approaches to mitral valve surgery are now increasingly employed. Whether minimally invasive mitral valve surgery is superior to conventional surgery is uncertain. Methods A retrospective analysis of patients who underwent mitral valve surgery via minithoracotomy or median sternotomy between 2012 and 2018. A propensity score-matched analysis was generated to eliminate differences in relevant preoperative risk factors between the two groups. Results Data from 525 patients were evaluated, 189 underwent minithoracotomy and 336 underwent median sternotomy. The 30 day mortality was similar between the minithoracotomy and conventional surgery groups (1 and 3%, respectively; p = 0.25). No differences were seen in the incidence of stroke (p = 1.00), surgical site infections (p = 0.09), or myocardial infarction (p = 0.23), or in total hospital cost (p = 0.48). However, the minimally invasive approach was associated with fewer patients receiving transfusions (59% versus 76% in the conventional group; p = 0.001) or requiring reoperation for bleeding (3% versus 9%, respectively; p = 0.03). There were no significant differences in 5 year survival between the minithoracotomy and conventional surgery groups (93% versus 86%, respectively; p = 0.21) and freedom from mitral valve reoperation (95% versus 94%, respectively; p = 0.79). Conclusions In patients undergoing mitral valve surgery, a minimally invasive approach is feasible, safe, and reproducible with excellent short-term outcomes; mid-term outcomes and efficacy were also seen to be comparable to conventional sternotomy.


Sign in / Sign up

Export Citation Format

Share Document